Milligan joined Gilead Sciences in 1990 and was appointed Chief Executive Officer in March 2016. He was appointed President in 2008, and from 2007 to 2016 served in the role of Chief Operating Officer as well. He previously held multiple leadership roles within Gilead, including the position of Chief Financial Officer from 2002 to 2007.
Milligan was named "Bay Area CFO of the Year" in 2006 for companies with revenues greater than $500 million, and he was named the top biotechnology industry CFO in the United States by Institutional Investor magazine in 2006, 2007 and 2008. He is a member of the boards of Biotechnology Industry Organization (BIO), the largest biotechnology industry organization, and Pacific Biosciences of California, Inc. He is also a Trustee of Ohio Wesleyan University.
Milligan received his BA from Ohio Wesleyan University, his PhD in biochemistry from the University of Illinois and was an American Cancer Society postdoctoral fellow at the University of California at San Francisco.
Board & Advisor Roles (3)Update
|Jul 26, 2016||SiliconBeat - Gilead plummets on weak outlook and downgrades|
|Jul 8, 2016||Business Wire - European Commission Grants Marketing Authorization for Gilead’s Epclusa|
|Mar 10, 2016||Business Wire - Gilead Sciences to Present at the Barclays Global Healthcare Conference on Tuesday, March 15|
|Jan 8, 2016||Business Wire - Gilead Sciences to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11|
|Jun 8, 2015||Business Wire - Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 9|
|May 27, 2015||Business Wire - Gilead Sciences to Present at the Bernstein 31st Annual Strategic Decisions Conference on Thursday, May 28|
|Mar 10, 2015||Business Wire - Gilead Sciences to Present at the Barclays Global Healthcare Conference on Wednesday, March 11|